Lotiglipron
A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Pfizer · Phase 1 · Terminated · Enrollment 16
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Period 1 | Healthy | n/r | n/r | n/r | n/r |
| Period 2 | Healthy | n/r | n/r | n/r | n/r |
| Period 3 | Healthy | n/r | n/r | n/r | n/r |
| Period 4 | Healthy | n/r | n/r | n/r | n/r |
| Period 5 | Healthy | n/r | n/r | n/r | n/r |
| Period 6 | Healthy | n/r | n/r | n/r | n/r |
| Period 7 | Healthy | n/r | n/r | n/r | n/r |
| Period 8 | Healthy | n/r | n/r | n/r | n/r |